ADK:CC News and Press, Diagnos Inc. From 03/27/24

2024-03-27 17:08:02 ET Starting clinical trials with the second largest hospital group in the U.S. Diagnos is an AI company. They have been a leader in artificial intelligence and healthcare technical services since 2001. Their company mission is to develop AI tools to assist ...

2024-03-27 17:08:02 ET An AI company Diagnos is a publicly-traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and development of applications such as CARA...

BROSSARD, Quebec, March 22, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence ( AI ) technologies, announces th...

BROSSARD, Quebec, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence ( AI ) technologies, is pleased to announce the appointment of...

Diagnos Inc. (ADK:CA) is expected to report $-0.01 for Q3 2024 A&W Revenue Royalties Income Fund (AW.UN:CA) is expected to report for quarter end 2023-12-31 Enerflex Ltd. (EFX:CA) is expected to report $-0.02 for Q4 2023 Spin Master Corp. Subordinate Voting Shares (TOY:CA) is expe...

BROSSARD, Quebec, Feb. 27, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence ( AI ) technologies, announces the...

BROSSARD, Québec, Feb. 23, 2024 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK), announces that on February 20, 2024, Mr. Tristram Coffin (the “Inve...

BROSSARD, Quebec, Feb. 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its FL AI RE platform based on Artificial Intelligence ( AI ), is...

B2Gold Corp. (BTO:CA) is expected to report $0.11 for Q4 2023 North American Construction Group Ltd. (NOA:CA) is expected to report $0.82 for Q4 2023 DREAM Unlimited Corp. Class A Subordinate Voting Shares (DRM:CA) is expected to report for Q4 2023 Whitecap Resources Inc. (WCP:CA) is ...

Manulife Financial Corporation (MFC:CA) is expected to report $0.84 for Q4 2023 Diagnos Inc. (ADK:CA) is expected to report $-0.01 for Q3 2024 Great-West Lifeco Inc. (GWO:CA) is expected to report $0.99 for Q4 2023 CAE Inc. (CAE:CA) is expected to report $0.24 for Q3 2024 West Fra...